AD20d
Kan ik nog wel een Nissan kopen, nu dat merk dreigt te verdwijnen?
Een fusie met Honda wordt overwogen en mogelijk komt er nog een derde merk bij, om nog sterker te staan. Als een merk dreigt om te vallen, ontstaat natuurlijk het risico van een snellere daling ...
Reuters23d
Merck to discontinue drug for bacterial infection
Dec 23 (Reuters) - Merck (MRK.N), opens new tab will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.
The Motley Fool25d
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
Merck just closed a deal to develop a weight-loss drug. The market appears to think Viking Therapeutics is threatened by that data. There's little reason to write off Viking here. First, let's get ...
Benzinga.com27d
Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials
Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...
FierceBiotech27d
Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead Sciences' lenacapivir, Merck & Co.'s islatravir is making further strides as a combination treatment with ...
Business Insider27d
Personalis receives $50M investment from Merck, extends pact with Moderna
Personalis (PSNL) announced agreements with long time collaborators Merck (MRK) and Moderna (MRNA) that accelerate the advancement of the company’s business strategy. The company has received an ...
Seeking Alpha27d
Merck-Hansoh deal for oral GLP-1 hurts obesity drug developers
Viking Therapeutics (NASDAQ:VKTX) and Structure Therapeutics (NASDAQ:GPCR) were among notable decliners on Wednesday after Merck (NYSE:MRK) partnered with Chinese biopharma Hansoh (OTCPK ...
FierceBiotech28d
Merck KGaA’s MilliporeSigma absorbs Dutch organoid maker HUB Organoids
Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is expected to be finalized by the end of 2024, according to a Dec ...
NBC New York28d
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...
BioPharma Dive28d
Merck moves into obesity with deal for Hansoh’s GLP-1 pill
Merck & Co. has made its first big move in obesity treatment, announcing Wednesday it is paying Hansoh Pharma $112 million for rights outside China to a preclinical pill that works similarly to the ...
BioSpace28d
Merck Joins Obesity Pill Race With Up to $2B Hansoh Deal
The Hansoh deal will let Merck compete in the crowded oral GLP-1 space alongside fellow pharma giants Eli Lilly, Novo Nordisk and Roche. Merck announced on Wednesday that it has inked a global ...